Oncology Clinical Trials in Anchorage, AK
As of August 2026, 38 paid clinical trials are recruiting for Oncology in Anchorage, Alaska. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
38 clinical trials for Oncology
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Top Research Study Locations in Anchorage
Researchers run research studies in Anchorage, AK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Alaska Medical Center | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 45 |
| Katmai Oncology Group | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8 | 38 |
| Alaska Women's Cancer Care | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Malignant Female Reproductive System Neoplasm | 38 |
| Alaska Oncology and Hematology LLC | Malignant Solid Neoplasm, Ovarian Carcinoma, Prostate Adenocarcinoma | 33 |
| Alaska Breast Care and Surgery LLC | Malignant Solid Neoplasm, Ovarian Carcinoma, Prostate Adenocarcinoma | 31 |
| Anchorage Associates in Radiation Medicine | Malignant Solid Neoplasm, Ovarian Carcinoma, Prostate Adenocarcinoma | 31 |
| Alaska Oncology and Hematology | Breast Neoplasms, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung | 9 |
| Anchorage Radiation Therapy Center | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 5 |
| Anchorage Oncology Centre | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 4 |
| Alaska Native Tribal Health Consortium | Child Obesity, Smoking Cessation | 2 |
| Alaska Oncology & Hematology, LLC | B-Cell Non-Hodgkins Lymphoma, Non-small Cell Lung Cancer | 2 |
| Alaska Oncology and Hematology, LLC | Non-small Cell Lung Cancer, Solid Tumours | 2 |
| Southcentral Foundation | Advance Care Planning, Hearing Loss | 2 |
| Alaska Womens Cancer Care | Endometrial Cancer, Malignant Neoplasm | 2 |
| AA Spine & Pain Clinic | Lumbar Spinal Stenosis | 1 |
| Alaska Children's EYE & Strabismus | Bradycardia, Strabismus | 1 |
| Alaska Heart Institute | Obstructive Hypertrophic Cardiomyopathy | 1 |
| Alaska Heart and Vascular Institute | Symptomatic Hypertrophic Cardiomyopathy (HCM) | 1 |
| Alaska Native Medical Center (ANMC) | Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III | 1 |
| Alaska Oncology and Hematology, Llc | HR+/HER2- Breast Cancer | 1 |
| Alaska Womens Cancer Care Akwcc | Ovarian Cancer | 1 |
| Anchorage Native Primary Care Center | Smoking Cessation | 1 |
| Decentralized / At-Home Participation (U.S.) | Healthy Adult Participants | 1 |
| Investigative | Solid Tumors | 1 |
| Joint Base Elmendorf-Richardson (JBER) | Chronic Pain | 1 |
Active & Upcoming Studies in Anchorage (2026)
Recruiting trials in Anchorage grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (68 active studies)
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · Fred Hutchinson Cancer Center
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · Phase 3 · BeOne Medicines
Mental health & behavior (2 active studies)
- Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT) · Southcentral Foundation
- Family-Based Financial Incentives Intervention for Smoking Cessation · Mayo Clinic
Diabetes & metabolic (1 active study)
- More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers · Alaska Native Tribal Health Consortium
Neurology & pain (1 active study)
- Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomized Controlled Trial · Phase 2 · Henry M. Jackson Foundation for the Advancement of Military Medicine
Cardiovascular (1 active study)
Pediatric (1 active study)
Common conditions studied in Anchorage
- Malignant Solid Neoplasm (5 active studies)
- Gastroesophageal Junction Adenocarcinoma (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
Leading research sponsors in Anchorage
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Anchorage?
There are approximately 99 recruiting clinical trials in Anchorage, Alaska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Anchorage pay participants?
Most recruiting trials in Anchorage compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Anchorage?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Anchorage?
The most common conditions under active study in Anchorage include Malignant Solid Neoplasm (5), Gastroesophageal Junction Adenocarcinoma (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Anchorage?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Anchorage on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Anchorage?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Anchorage?
Recruiting research sites in Anchorage include Providence Alaska Medical Center, Katmai Oncology Group, Alaska Women's Cancer Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Anchorage right now?
The largest active categories in Anchorage are Cancer & tumors (68), Mental health & behavior (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.